gms | German Medical Science

Deutscher Rheumatologiekongress 2022, 50. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 36. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), 32. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)

31.08. - 03.09.2022, Berlin

Elevated zonulin and calprotectin levels in patients with rheumatoid arthritis indicate subclinical bowel inflammation

Meeting Abstract

Search Medline for

  • Monika Reuss-Borst - Schwerpunktpraxis f. Rheumatologie, Bad Bocklet; Georg-August Universität Göttingen, Göttingen
  • Christina Heidt - Schwerpunktpraxis f. Rheumatologie, Bad Bocklet; Universtität Münster, Münster
  • Andreas Rüffer - Enterosan Labor Diagnostik, Labor LS SE & Co. KG, Bad Bocklet-Großenbrach

Deutsche Gesellschaft für Rheumatologie. Deutsche Gesellschaft für Orthopädische Rheumatologie. Gesellschaft für Kinder- und Jugendrheumatologie. Deutscher Rheumatologiekongress 2022, 50. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 36. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), 32. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR). Berlin, 31.08.-03.09.2022. Düsseldorf: German Medical Science GMS Publishing House; 2022. DocRA.06

doi: 10.3205/22dgrh154, urn:nbn:de:0183-22dgrh1540

Published: August 31, 2022

© 2022 Reuss-Borst et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Introduction: The pathophysiology of rheumatoid arthritis (RA) is still poorly understood. Increasingly, research is focusing on the intestine as the largest immunological organ and the “gut-joint-axis”. Microbial dysbiosis as well as a leaky gut and resulting subclinical inflammation as possible trigger mechanisms of arthritis point to the importance of a “healthy” diet for the prevention/treatment of RA.

Methods: In this clinical study, the dietary behaviour of 42 patients with RA (median age 60.5 years, female proportion 62%, median BMI 27.2 kg/m2) and a median disease duration of 3.5 years was analyzed using a dietary protocol for at least 3 days each (PRODI nutrition software). Among other things, the intake of dietary fiber was examined. Zonulin, calprotectin and the short-chain fatty acids butyrate, acetate and propionate were determined in parallel in the stool.

Results: Mean dietary fiber intake was 16.0 gr/d (min. 4.2 g/d – max. 28.7 g/d). Men (15.9 g/d) and women (16.1 g/d) did not differ in dietary fiber intake. Intake of water-soluble dietary fiber that are degradable by symbionts was very low with 5.2 gr/d. Zonulin was significantly elevated at 343.81 ng/g (<61 ng/g) ranging from 45.4 ng/g to 625.4 ng/g. Zonulin levels did not correlate with age, sex and disease activity or therapy. Calprotectin was also elevated with a mean value of 79.65 µg/g (<50 µg/g) (Min. 3.1 µg/g – Max 706 µg/g). Mean values for butyrate, acetate and propionate were 7.8 µmol/g, 35.2 µmol/g and 9.0 µmol/g, respectively, with a considerable spread.

Conclusion: 41/42 patients had significantly elevated fecal zonulin levels. Zonulin increases intestinal permeability by decreasing tight junction proteins and induces T-cell mediated mucosal inflammation. Calprotectin as a marker of intestinal inflammation was also increased in 23/42 patients. Dietary fiber intake of RA patients was significantly below current DGE recommendations (>30g/day). It is postulated that an increase in dietary fiber intake could have positive effects on zonulin and calprotectin by reducing subclinical intestinal inflammation.